Two physicians have joined the radiation oncology team at West Michigan Cancer Center & Institute for Blood Disorders (WMCC), a collaboration of Ascension Borgess and Bronson Healthcare Group.
Daniel Chamberlain, MD, is WMCC’s new division chief of radiation oncology. Dr. Chamberlain has 14 years’ experience in clinical and academic medicine, most recently as a faculty member at Banner MD Anderson Cancer Center in Gilbert, AZ. Prior to his work there, he served as clinical director of radiation oncology at the Greenwich campus of the Yale Smilow Cancer Center in Greenwich, CT. Dr. Chamberlain earned his medical degree from the Columbia University College of Physicians and Surgeons in New York City. He completed a medical/surgical internship at Mayo Clinic Arizona in Scottsdale and a residency in radiation oncology at Yale University School of Medicine through Yale New Haven Hospital in New Haven, CT. Dr. Chamberlain is board certified in radiation oncology and specializes in lung cancer, breast cancer, lymphoma, brain tumors and head & neck cancers.
Brandon Mancini, MD, MBA, is a board certified radiation oncologist and Michigan native who joined WMCC after two years as medical director at Mercy Health Lacks Cancer Center in Grand Rapids. During his time there, Dr. Mancini also served as a clinical assistant professor in the department of radiation oncology through the University of Michigan in Ann Arbor. Dr. Mancini earned his medical degree from Wayne State University in Detroit and completed a Master of Business degree from Yale School of Management in New Haven, CT. He remained in New Haven to complete an internship and residency in radiation oncology at Yale-New Haven Hospital. Dr. Mancini specializes in gastrointestinal cancers, prostate cancer, breast cancer, gynecologic cancers and lymphoma.